Skip to search formSkip to main contentSkip to account menu

Mood Stabilizer [EPC]

Known as: Mood Stabilizer 
National Institutes of Health

Related topics

Related topics

4 relations
Antidepressive AgentsAntimanic AgentsMood DisordersMood Stabilizers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
Objective The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was first published in 2002 through an expert… 
2015
2015
Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study.
Review
2015
Review
2015
Korean Medication Algorithm Project for Bipolar Disorder: third revision
Objective To constitute the third revision of the guidelines for the treatment of bipolar disorder issued by the Korean… 
Review
2011
Review
2011
When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations
Review
2009
Review
2009
Revised Korean medication algorithm for bipolar disorder
The rapid progress in treatments for bipolar disorder makes it necessary to revise the Korean Medication Algorithm Project for… 
Highly Cited
2008
Highly Cited
2008
Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study
Objective: Practice guidelines for the initial treatment of bipolar II (BP II) major depressive episode (MDE) recommend mood… 
Review
2005
Review
2005
Newer treatment studies for bipolar depression.
OBJECTIVE Depressive symptoms of bipolar disorder have more negative impact on a patient's life than manic symptoms. This review… 
2005
2005
Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study
Highly Cited
2004
Highly Cited
2004
The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program.
Review
1996
Review
1996
Alopecia and mood stabilizer therapy.
Alopecia is a common side effect in patients managed on the mood stabilizers lithium, valproate, and carbamazepine. Clinicians… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)